What was filed
Jagsonpal Pharmaceuticals told the NSE and BSE on 17 July 2026 that it has completed the acquisition of an 85% equity stake in Aequitas Healthcare Private Limited. The disclosure was made under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
The notice closes a deal the company first disclosed on 29 June 2026, with further updates on 7 July and 8 July 2026. This filing marks the transaction moving from proposed to completed.
What the filing does not say
The intimation is brief and confirmatory. It states only that the 85% stake has been acquired; it does not restate the consideration, valuation, funding, or Aequitas's business details.
A holder seeking the commercial terms would need to look to the 29 June, 7 July and 8 July disclosures cited by the company, as this notice is a completion confirmation.